A Phase IV, Open Label, Single Arm, Multicenter, Extension Study of Adefovir Dipivoxil for Korean Patients With Chronic Hepatitis B(CHB) Who Have Completed ADF 103814.
Phase of Trial: Phase IV
Latest Information Update: 14 Dec 2010
At a glance
- Drugs Adefovir dipivoxil (Primary)
- Indications Hepatitis B
- Focus Therapeutic Use
- Sponsors GlaxoSmithKline
- 27 Oct 2008 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 28 Feb 2008 Actual end date (Apr 2008) added as reported by ClinicalTrials.gov.
- 02 Mar 2007 New trial record.